NCT05522387 2026-02-27An Open-Label Extension of XPro1595 in Patients With Alzheimer's DiseaseInmune Bio, Inc.Phase 2 Terminated11 enrolled
NCT00004682 2015-03-25Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia GravisFDA Office of Orphan Products DevelopmentPhase NA Terminated100 enrolled